Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Shenzhen - Delayed Quote CNY

Hualan Biological Vaccine Inc. (301207.SZ)

Compare
17.84
-0.29
(-1.60%)
As of 1:15:52 PM GMT+8. Market Open.

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Ms. Wenjue An GM & Director -- -- 1989
Ms. Ruowen Pan Deputy GM & Director -- -- 1968
Mr. Chengyu Lv CFO & Secretary -- -- 1981

Hualan Biological Vaccine Inc.

Jia No. 1-1, Hualan Avenue
Xinxiang, 453003
China
86 37 3355 9991 https://www.hualanbacterin.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
770

Description

Hualan Biological Vaccine Inc. engages in the research, development, production, and sale of vaccines in China. It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, influenza A (H1N1) virus split vaccines, ACYW135 group meningococcal polysaccharide vaccines, recombinant hepatitis B vaccines, group A and C meningococcal polysaccharide vaccines, freeze-dried human rabies vaccine, and tetanus vaccines, as well as genetic engineering of biological products. The company also sells self-produced products. The company was founded in 2005 and is based in Xinxiang, China.

Corporate Governance

Hualan Biological Vaccine Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

June 14, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers